09:00     Registration, partnering meetings, and networking

09:30     Welcome and introduction
Jochen Schwenk, Professor of Translational Proteomics, KTH Royal Institute of Technology

09:35     Implementation of AI-based precision pathology
Johan Hartman, Professor/Senior Physician, Department of Oncology-Pathology, Karolinska Institutet

10:00     The Future of Lab & Diagnostics – Moving from ambition to outcome
Bita Sehat, Partner, Trill Impact Advisory

10:25     Coffee, partnering meetings, and networking

11:00     Ultra-rapid diagnostics for personalised antibiotic treatment
Sara Thorslund, CEO and Co-founder, Gradientech

11:25     Transforming immunoassays with BOLD: Ultrasensitive detection of low-abundance biomolecules
Peter Stenlund, Principal Scientist, Cavidi

11:50     Advancement in molecular tools for biomarker detection and characterization
Masood Kamali-Moghaddam, Professor of Molecular Diagnostics, Uppsala University

12:15     Lunch, partnering meetings, and networking

13:10     Towards clinical diagnostics driven by plasma profiling and large biomarker panels
Fredrik Edfors, Assistant Professor and Docent in Biotechnology, KTH Royal Institute of Technology

13:35     Next generation microsampling technology: Painless access to untapped medical information
Federico Ribet, CTO and Co-founder, Samplimy Medical

14:00     Cross-border health threats: The Swedish Public Health Agency’s coordination of the EU reference laboratory for emerging, rodent-borne and zoonotic viral pathogens
Johan Aarum, Head of Unit, Public Health Agency of Sweden 

14:25     Coffee, partnering meetings, and networking

14:50     Are antimicrobial-resistant bacteria capable of causing disease? Insights from Ukraine
Kristian Riesbeck, Professor in Clinical Bacteriology, Lund University

15:15     Light loss correction for confocal imaging of 3D cell cultures
Petter Säterskog, CEO and Co-founder, Ciprocity

15:40     From diagnostics to large-scale purification: Versatility of Streptavidin and Strep-Tactin®XT
Benedikt Ni, PhD, Account Manager, IBA Lifesciences

16:05      Precision commercialization: Leveraging the overlooked to maximize global medtech revenue
Walter Rangel Campos, VP of Business Development, VIDEM

16:30    Concluding remarks

16:35     End of programme